These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 10686314

  • 1. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F.
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Minimizing calcineurin inhibitor drugs in renal transplantation.
    Flechner SM.
    Transplant Proc; 2003 May; 35(3 Suppl):118S-121S. PubMed ID: 12742481
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM, Donadi MO, Oliveira ML, Ponte CN, Pinheiro PM.
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective CellCept therapy in high-risk renal transplant recipients.
    Isenberg A, Singh TP, Shen GK, Freed BM, Conti DJ.
    Transplant Proc; 1998 Jun; 30(4):1188-9. PubMed ID: 9636480
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z, Wałaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D.
    Ann Transplant; 2002 Jun; 7(3):28-31. PubMed ID: 12465429
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 16. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C, Hollenbeck M, Ivens K, Heering P, Hetzel GR, Grabensee B.
    Transplant Proc; 2001 Feb 27; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract] [Full Text] [Related]

  • 17. Steroid withdrawal in kidney transplantation: the subgroup fallacy.
    Steiner RW.
    Transplantation; 2011 Mar 15; 91(5):e27-8. PubMed ID: 21336084
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A, Herrero JC, Morales E, Carreño A, Dominguez-Gil B, Cirujeda A, Praga M, Ortuño T, Hernandez E, Delgado M, Andres A, Morales JM.
    Transplant Proc; 1999 Sep 15; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM, Lloveras J, Fernández-Crespo P, Mir M, Iñigo V, Manresa JM, Masramón J.
    Transplant Proc; 1999 Sep 15; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.